Mavacamten’s Safety and Efficacy Profile in the PIONEER Study Maintained Through OneYear in Open-Label Extension Study of 12 Patients with Symptomatic, Obstructive […]
Cannabinoid content per gram only slightly lower than identical strains grown indoorsCritical quality control tests successfulApproximately 1,000 kg yield per […]
– Treatment with KORSUVA Injection resulted in statistically significant reduction in pruritus intensity and improvement in itch-related quality of life […]